The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes
Open accessAbstract
Background—: The first generation of the bioresorbable everolimus drug-eluting vascular scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal loss. Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified. Methods and Results—: Quantitative coronary angiography, intravascular ultrasound with analysis of radiofrequency backscattering, and as an optional assessment, optical coherence tomography (OCT) were performed at baseline and at a 6-month follow-up. Forty-five patients successfully received a single bioresorbable everolimus drug-eluting vascular scaffold. One patient had postprocedural release of myocardial enzyme without Q-wave occurrence; 1 patient with OCT-diagnosed disruption of the scaffold caused by excessive postdilatation was treated 1 month later with a metallic drug-eluting stent. At follow-up, 3 patients declined recatheterization, 42 patients had quantitative coronary angiography, 37 had quantitative intravascular ultrasound, and 25 had OCT. Quantitative coronary angiography disclosed 1 edge restenosis (1 of 42; in-segment binary restenosis, 2.4%). At variance with the ultrasonic changes seen with the first generation of bioresorbable everolimus drug-eluting vascular scaffold at 6 months, the backscattering of the polymeric struts did not decrease over time, the scaffold area was reduced by only 2.0% with intravascular ultrasound, and no change was noted with OCT. On an intention-to-treat basis, the late lumen loss amounted to 0.19±0.18 mm with a limited relative decrease in minimal luminal area of 5.4% on intravascular ultrasound. OCT showed at follow-up that 96.8% of the struts were covered and that malapposition of at least 1 strut, initially observed in 12 scaffolds, was detected at follow-up in only 3 scaffolds. Mean neointimal growth measured by OCT between and on top of the polymeric struts equaled 1.25 mm 2 , or 16.6% of the scaffold area. Conclusion—: Modified manufacturing process of the polymer and geometric changes in the polymeric platform have substantially improved the medium-term performance of this new generation of drug-eluting scaffold to become comparable to those of current drug eluting stents. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT00856856.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Self-citationUniversal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Task Force Members, Thygesen, K., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,541
Self-citationTunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Mintz, G. S., Nissen, S. E., Anderson, W. D., Bailey, S. R., Erbel, R., Fitzgerald, P. J., Pinto, F. J., Rosenfield, K., Siegel, R. J., Tuzcu, E. M., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01175-5 · Cited by 2,185
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Patterns and Mechanisms of In-Stent Restenosis: A Serial Intravascular Ultrasound Study
Hoffmann, R., Mintz, G. S., Dussaillant, G. R., Popma, J. J., Pichard, A. D., Satler, L. F., Kent, K. M., Griffin, J., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1247 · Cited by 1,247
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis
Nair, A., Kuban, B. D., Tuzcu, E. M., Schoenhagen, P., Nissen, S. E., & Vince, D. G. (2002) · Circulation · doi:10.1161/01.cir.0000035654.18341.5e · Cited by 1,129
Erbel, R., Di Mario, C., Bartunek, J., Bonnier, J., de Bruyne, B., Eberli, F. R., Erne, P., Haude, M., Heublein, B., Horrigan, M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60853-8 · Cited by 907
Self-citationPrati, F., Regar, E., Mintz, G. S., Arbustini, E., Di Mario, C., Jang, I.-K., Akasaka, T., Costa, M., Guagliumi, G., Grube, E., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp433 · Cited by 880
Self-citationSerruys, P. W., Ormiston, J. A., Onuma, Y., Regar, E., Gonzalo, N., Garcia-Garcia, H. M., Nieman, K., Bruining, N., Dorange, C., Miquel-Hébert, K., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60325-1 · Cited by 820
Self-citationOrmiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60415-8 · Cited by 712
Self-citationAssessment of the SYNTAX score in the Syntax study
Serruys, P., Onuma, Y., Garg, S., Sarno, G., van den Brand, M., Kappetein, A.-P., Van Dyck, N., Mack, M., Holmes, D., Feldman, T., et al. (2009) · EuroIntervention · doi:10.4244/eijv5i1a9 · Cited by 632
Self-citationACC/AHA/SCAI Practice Guidelines, February 21, 2006
(2006) · Circulation · doi:10.1161/circulationaha.106.173220 · Cited by 422
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
Togni, M., Windecker, S., Cocchia, R., Wenaweser, P., Cook, S., Billinger, M., Meier, B., & Hess, O. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.062 · Cited by 373
Self-citationOng, A. T. L., Serruys, P. W., Mohr, F. W., Morice, M.-C., Kappetein, A. P., Holmes, D. R., Mack, M. J., van den Brand, M., Morel, M.-A., van Es, G.-A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.017 · Cited by 338
Self-citationNair, A., Mp, M., Kuban, B. D., & Vince, D. G. (2007) · PubMed · Cited by 320
Onuma, Y., Serruys, P. W., Perkins, L. E. L., Okamura, T., Gonzalo, N., García-García, H. M., Regar, E., Kamberi, M., Powers, J. C., Rapoza, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.921528 · Cited by 319
Self-citationOrmiston, J. A., & Serruys, P. W. S. (2009) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.859173 · Cited by 305
Self-citationSmith, S. C., Jr. (2006) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/q4vp-sw36 · Cited by 177
Tanimoto, S., Serruys, P. W. J. C., Thuesen, L., Dudek, D., Bruyne, B. D., Chevalier, B., & Ormiston, J. A. (2007) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21136 · Cited by 151
Self-citationBiodegradable stents: they do their job and disappear.
Waksman, R. (2006) · PubMed · Cited by 141
Tanimoto, S., Bruining, N., van Domburg, R. T., Rotger, D., Radeva, P. I., Ligthart, J. M. R., & Serruys, P. W. J. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.024 · Cited by 95
Self-citationOkamura, T., Garg, S., Gutiérrez‐Chico, J. L., Shin, E., Onuma, Y., García‐García, H. M., Rapoza, R. J., Sudhir, K., Regar, E. S., & Serruys, P. W. J. C. (2010) · EuroIntervention · doi:10.4244/eijv5i8a157 · Cited by 76
Self-citationSihan, K., Botha, C. P., Post, F. H., de Winter, S., Gonzalo, N., Regar, E. S., Serruys, P. W. J. C., Hamers, R., & Bruining, N. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22125 · Cited by 50
Self-citation
Cited by
Serruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Self-citationOnuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Self-citationHaude, M., Erbel, R., Erne, P., Verheye, S., Degen, H., Böse, D., Vermeersch, P., Wijnbergen, I., Weissman, N., Prati, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61765-6 · Cited by 423
Self-citationPrati, F., Guagliumi, G., Mintz, G. S., Costa, M., Regar, E., Akasaka, T., Barlis, P., Tearney, G. J., Jang, I.-K., Arbustini, E., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs095 · Cited by 400
Self-citationClinical Impact of OCT Findings During PCI
Prati, F., Romagnoli, E., Burzotta, F., Limbruno, U., Gatto, L., La Manna, A., Versaci, F., Marco, V., Di Vito, L., Imola, F., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.08.013 · Cited by 360
Metadata
- Authors
- Serruys, P. W., Onuma, Y., Ormiston, J. A., de Bruyne, B., Regar, E., Dudek, D., Thuesen, L., Smits, P. C., Chevalier, B., McClean, D., Koolen, J., Windecker, S., Whitbourn, R., Meredith, I., Dorange, C., Veldhof, S., Miquel-Hebert, K., Rapoza, R., & García-García, H. M.
- Venue
- Circulation
- Published
- 2010-11-30
- Volume
- 122
- Issue
- 22
- Pages
- 2301-2312
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2762639187
- Cited by
- 307
- References
- 26
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.